Microgestin 24 Fe Kit
Product Images NDC 51862-648

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Microgestin 24 Fe (NDC 51862-648). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Instructions for administration of Microgestin 24 Fe kit, detailing dosing schedules for starting combined oral contraceptives (COCs) with Day 1 or Sunday start, including tablet color coding of pale yellow active tablets and brown inactive tablets. It also includes guidance for switching from other contraceptive methods and specific directions for transdermal patch, vaginal ring, injection, intrauterine contraceptive, and implant transitions.*

FDA Label Image

2 (Image 02)

Instructions for missed Microgestin 24 Fe tablets detailing steps for missed active tablets during Weeks 1 through 4, including when to take missed tablets and the recommendation to use additional non-hormonal contraception if sex occurs within 7 days after missed tablets. The instructions specify actions for missing one tablet, two consecutive in Weeks 1 or 2, and multiple missed tablets in Weeks 3 or 4 or at any time.*

FDA Label Image

3 (Image 03)

Chemical structure of Ethinyl Estradiol, a component of the combination drug Microgestin 24 Fe. The image shows a molecular diagram with rings and functional groups characteristic of this synthetic estrogen.*

FDA Label Image

4 (Image 04)

Chemical structure of Norethindrone acetate showing its steroidal backbone with acetate group and triple bond characteristic features.*

FDA Label Image

5 (Image 05)

A line graph depicting mean plasma norethindrone concentration-time profiles following single- and multiple-dose oral administration to healthy female volunteers under fasting conditions. The X-axis shows time in hours (0 to 60), and the Y-axis shows norethindrone concentration in pg/mL (0 to 14000). Two curves represent Day 1 (single dose) and Day 24 (multiple doses).*

FDA Label Image

6 (Image 06)

A line graph displaying mean plasma Ethinyl Estradiol concentration (pg/mL) over time (hours) following single- and multiple-dose oral administration of norethindrone acetate and ethinyl estradiol tablets to healthy female volunteers under fasting conditions (n=17). Concentration peaks early, then declines over 60 hours, comparing Day 1 and Day 24 dosing profiles.*

FDA Label Image

7 (Image 07)

A pharmacokinetic summary table presenting Norethindrone (NE), Ethinyl Estradiol (EE), and Sex Hormone Binding Globulin (SHBG) plasma concentration parameters after single and multiple oral doses of Norethindrone Acetate and Ethinyl Estradiol tablets in healthy female volunteers (n=17). Parameters include maximum concentration (Cmax), time to Cmax (tmax), area under the curve (AUC0–24), minimum concentration (Cmin), elimination half-life (t½), and average plasma concentration (Cavg) under fasting conditions.*

FDA Label Image

8 (Image 08)

An illustration showing a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, with corresponding pregnancy rates per 100 women per year listed on the left side. On the right, boxed lists categorize birth control methods by effectiveness, including sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

9 (Image 09)

An instructional diagram for Microgestin 24 Fe (Norethindrone acetate/Ethinyl Estradiol and Ferrous Fumarate) birth control kit. It shows placement of a day label sticker to align with the start day of menstruation, indicating how to start with Sunday or Day 1. The diagram includes directions to take pills from left to right each week, depicting active pale yellow pills and inactive brown pills, with a hand placing a day label sticker above the pill pack days of the week.*

FDA Label Image

10 (Image 10)

FDA Label Image

11 (Image 11)

Microgestin 24 Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets) 1 mg/0.02 mg kit packaging label from Mayne Pharma Inc. The label states it contains 3 blister cards of 28 tablets each, providing 24 days of active therapy. Dosage instructions, warnings, and storage information are included along with barcodes and the NDC 51862-648.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.